| 13828 |
3-Deazaneplanocin A
|
|
102052-95-9 |
≥98%
|
|
|
2011-02-18
|
231.492454617205
|
3-deazaneplanocin-a
|
DZNep; NSC 617989
|
EZH2 KMT6 methyltransferases histones cancer epigenetics panobinostat 3deazaneplanocin 3-cyclopentene-1,2-diol deriv Adenosine Adenocard |
231.492454617205
|
| 10495 |
4-iodo-SAHA
|
|
1219807-87-0 |
≥98%
|
|
|
2011-01-10
|
21.372640883977
|
4-iodo-saha
|
|
anti-cancers HDACs inhibitors anti-proliferation 4-Hydroxy-5-iodo-3-nitrophenyl)acetyl
4-Hydroxy-3-iodo-5-nitrophenyl)acetyl 5-Iodo-4-hydroxy-3-nitrophenacetyl 5 Iodo 4 hydroxy 3 nitrophenacetyl
Nitrohydroxyiodophenylacetate
Hydroxyiodonitrophenylacetate
Hapten NIP Acetyl Acetyl Hapten NIP NIP Acetyl Hapten
NIP-Hapten NIP Hapten |
21.372640883977
|
| 10547 |
4-pentynoyl-Coenzyme A (trifluoroacetate salt)
Exclusive
|
|
- |
≥95%
|
|
✓ |
2010-08-11
|
9.999471111111
|
4-pentynoyl-coenzyme-a-trifluoroacetate-salt
|
Click Tag™ 4-pentynoyl-CoA
|
50347-32-5 click chemistry proteins acetylation posttranslational post-translational post translational modify modification acetyl-CoA acetyl-coenzyme A lysine histons acetyl click-it click it click tag click-tag 14-pentynoyl-coa(adamantyl) indole |
9.999471111111
|
| 13725 |
Acetyl Lysine Polyclonal Antibody-biotin
|
|
- |
|
|
|
2009-12-04
|
1.385359116022
|
acetyl-lysine-polyclonal-antibody-biotin
|
|
antibodies WB western blots immunoblotting blotting immunoprecipitation IP ELISA immunofluorescence IF proteins conjugated HATs HDACs histone acetyltransferases deacetylated deacetylases proteins cancers anti-cancer anticancer anti post-translational |
1.385359116022
|
| 13726 |
Acetyl Lysine Polyclonal Antibody HRP Conjugate
|
|
- |
|
|
|
2009-12-04
|
1.385359116022
|
acetyl-lysine-polyclonal-antibody-hrp-conjugate
|
|
antibodies WB western blots immunoblotting blotting immunoprecipitation IP ELISA immunofluorescence IF proteins conjugated HATs HDACs histone acetyltransferases deacetylated deacetylases proteins cancers anti-cancer anticancer anti |
1.385359116022
|
| 13144 |
Anacardic Acid
|
|
16611-84-0 |
≥98%
|
|
|
2010-02-12
|
5.862559731964
|
anacardic-acid
|
6-pentadecyl Salicylic Acid
|
HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 |
5.862559731964
|
| 10575 |
Apicidin
New
|
|
183506-66-3 |
≥98%
|
|
|
2012-01-27
|
21.579683293496
|
apicidin
|
OSI 2040
|
funfal toxins malaria HDAC HAT histones deacetylase transcriptions epigenetics anticancer anti-cancer antiproliferation antiparasitic anti-proliferation anti-parasitic apicomplexan parasites HDAC3 HDAC-3 NcoR HDAC3/NcoR class I HDACs p21 WAF1/Cip1 WAF1 Cip1 gelsolin cells cycle morphology inhibits inhibitors inhibitions chromatin cancers deacetylase modification |
21.579683293496
|
| 10946 |
Ash2L (human recombinant)
|
|
- |
≥90%
|
|
|
2011-06-29
|
12.972715102576
|
ash2l-human-recombinant
|
Set1/Ash2 Histone Methyltransferase Complex Subunit Ash2 Isoform A; Absent, small, or homeotic discs 2-like
|
epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex human homolog Drosophilia ash2 transcription |
12.972715102576
|
| 13124 |
BIX01294 (hydrochloride hydrate)
|
|
- |
≥98%
|
|
|
2009-12-03
|
37.100217184225
|
bix01294-hydrochloride-hydrate
|
|
euchromatin genes expressions epigenetics G9a histones methyltransferase HMTase embryogenesis imprinting lymphocytes development inhibitors proteins GLP stem cells 935693-62-2 |
37.100217184225
|
| 11507 |
BRD1 bromodomain (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-03-01
|
15.723401238237
|
brd1-bromodomain-human-recombinant
|
Bromodomain containing 1; DKFZp686F0325; BR140-like protein; BRL; BRPF1; BRPF2; Bromodomain and PHD finger-containing protein 2
|
BRD1 genes expression histones chromatin acetylation bromodomains epigenetics schizophrenia bipolar disorders BRD-1 BRDs |
15.723401238237
|
| 600520 |
BRD4 bromodomain 1 TR-FRET Assay Kit
New
|
|
- |
|
|
|
2012-04-25
|
87.870599080453
|
brd4-bromodomain-1-tr-fret-assay-kit
|
|
kits assays measures measurements acetylations histones lysines epigenetics regulations genes transcriptions acetylated residues small proteins bromodomains nucleosomes chromatins structures expression BET family tandem Extra Terminal BRD2 BRD3 BRDT cells cellular inflammatory inflammation mitosis viral host virus viral/host interactions binds binding tails couples marks transcriptional targets promoters molecules inhibitors bromodomain/histone I-BET JQ-1 therapeutics human diseases complexes activated macrophages protection protects bacteria-induced sepsis lipopolysaccharides lipopolysaccharide-triggered endotoxic shock enantiomerically pure (+)-JQ1 (+)-JQ-1 2 bromodomain-peptides displacement inhibits inhibitors probes oncogenesis oncology cancers homogeneous TR-FRET time-resolved fluorescence resonance energy transfer characterization bromodomain/acetylated interactions fluorophores europium Eu3+ chelates biotinylated ligands allophycocyanin APC-labeled avidins biotins |
87.870599080453
|
| 600530 |
BRD4 bromodomain 2 TR-FRET Assay Kit
New
|
|
- |
|
|
|
2012-04-26
|
88.919981796503
|
brd4-bromodomain-2-tr-fret-assay-kit
|
|
kits assays measures measurements acetylations histones lysines epigenetics regulations genes transcriptions acetylated residues small proteins bromodomains nucleosomes chromatins structures expression BET family tandem Extra Terminal BRD2 BRD3 BRDT cells cellular inflammatory inflammation mitosis viral host virus viral/host interactions binds binding tails couples marks transcriptional targets promoters molecules inhibitors bromodomain/histone I-BET JQ-1 therapeutics human diseases complexes activated macrophages protection protects bacteria-induced sepsis lipopolysaccharides lipopolysaccharide-triggered endotoxic shock enantiomerically pure (+)-JQ1 (+)-JQ-1 1 bromodomain-peptides displacement inhibits inhibitors probes oncogenesis oncology cancers homogeneous TR-FRET time-resolved fluorescence resonance energy transfer characterization bromodomain/acetylated interactions fluorophores europium Eu3+ chelates biotinylated ligands allophycocyanin APC-labeled avidins biotins |
88.919981796503
|
| 11509 |
BRD9 bromodomain (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-04-20
|
65.853947880323
|
brd9-bromodomain-human-recombinant
|
Bromodomain-containing 9
|
BRD9 genes expressions histones chromatin acetylation bromodomains epigenetics BET domains transcription Extra Terminal domain BRDs BRDT inflammatory mitosis viral/host interactions Rhabdomyosarcoma antigen MU-RMS-40.8 |
65.853947880323
|
| 11548 |
BRDT bromodomain 1 (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-03-01
|
15.723401238237
|
brdt-bromodomain-1-human-recombinant
|
BRD6; CT9; RING3-like protein; Cancer/testis antigen 9; BRD-containing protein testis specific
|
BRD-T genes expression histones chromatin acetylation bromodomains epigenetics BET domains Extra Terminal RING3 PEST Bromodomain testis specific BRDs BRD T |
15.723401238237
|
| 11284 |
BRG1 bromodomain (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-03-05
|
12.837710969321
|
brg1-bromodomain-human-recombinant
|
BRG1-associated factor 190A; BAF190A Mitotic growth and transcription activator; ATP-dependent helicase SMARCA4; Protein BRG-1
|
BRG1 genes expressions histones chromatin acetylation bromodomains epigenetics SWI/SNF SWI SNF cancers tumors suppressors Protein brahma homolog 1 |
12.837710969321
|
| 11289 |
BRM bromodomain (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-03-01
|
8.128331573859
|
brm-bromodomain-human-recombinant
|
SWI/SNF ATPase; SMARCA2A/B
|
BRD1 genes expressions histones chromatin acetylation bromodomains epigenetics SWI/SNF SWI SNF ATP dependent chromatin SWI/SNF-related, matrix associated, actin-dependent regulator of chromatin |
8.128331573859
|
| 10009797 |
CAY10591
Exclusive
|
|
839699-72-8 |
≥98%
|
|
✓ |
2008-04-21
|
39.731274401472
|
cay10591
|
Sirtuin 1 Activator 3; SIRT1 Activator 3
|
p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic |
39.731274401472
|
| 13156 |
Chaetocin
|
|
28097-03-2 |
≥95%
|
|
|
2010-10-18
|
18.632886024146
|
chaetocin
|
|
histones methyltransferases HMTs genes expressions epigenetics inhibitors oxidative stress cancers theoredoxin reductase-1 TrxR1 inhibits inhibition chetocin chaetocin A (+)-chaetocin piperazines |
18.632886024146
|
| 13686 |
Chidamide
|
|
743420-02-2 |
≥98%
|
|
|
2010-08-10
|
39.909907100471
|
chidamide
|
|
HDACs histones deacetylase H3 acetylation colons cancers cells inhibitors inhibits inhibiton LoVo HT-29 HT29 HT 29 cycle arrest chidamides oncogenic signalling signaling kinases Benzamides |
39.909907100471
|
| 11010 |
Core Histones (human)
|
|
- |
≥95%
|
|
|
2011-10-07
|
18.612207388499
|
core-histones-human
|
HeLa Core Histones
|
histones DNA nucleosomes chromatin HDAC HAT HMT HDEM H2A H2B H3 H4 proteins acetylation genes transcriptions methylation demethylation phosphorylation regulation |
18.612207388499
|
| 10671 |
coumarin-SAHA
|
|
- |
98%
|
|
|
2011-02-03
|
15.155264404104
|
coumarin-saha
|
coumarin-Suberoylanilide Hydroxamic Acid
|
SAHA HDAC inhibitor fluorescent probe screening assay histone deacetylase inhibits inhibition Vorinostat Zolinza™ Pyrrolidinediones
Succinimides Butanimides |
15.155264404104
|
| 11012 |
Delphinidin chloride
Exclusive New
|
|
528-53-0 |
≥98%
|
|
✓ |
2012-03-06
|
51.662269285860
|
delphinidin-chloride
|
Ephdine
|
diseases cancers cardiovascular tyrosines kinases vasorelaxation smooth muscles chlorides Cl vasorelaxants inhibitors inhibition inhibits EGFRs epidermal epidermis growth factors receptors HATs histones acetyltransferases anthocyanidins plants pigments anthocyanins blue red colors flowers fruits wines nitric oxides NOs vascular endothelium signaling signalling epithelial estrogens ERa ERalpha ER.alpha. ERα apoptosis cells death autophagy phagocytosis delphinidol 13270-61-6 IdB 1056 IdB-1056 |
51.662269285860
|
| 700390 |
Demethylase (Jumonji-type) Activity Assay Kit
|
|
- |
|
|
|
2010-05-26
|
28.154262474787
|
demethylase-jumonji-type-activity-assay-kit
|
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 |
28.154262474787
|
| 10770 |
DNA Methyltransferase 3L (human recombinant)
|
|
- |
≥95%
|
|
|
2011-06-08
|
2.540563835710
|
dna-methyltransferase-3l-human-recombinant
|
DNMT3L; DNMT3-Like Protein
|
DNA methyltransferases s-adenosylmethionine CpG methylation lysines proteins DNMT3a DNMT3b histones cysteine ADD PWWP mTase |
2.540563835710
|
| 11178 |
DPY-30 (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-01-05
|
14.152052839174
|
dpy-30-human-recombinant
|
DPY-30-like protein; hDPY-30; SAF19
|
epigenetics methyltransferase histones H3K4 genes regulations MLL proteins subunits Ash2L MLL sore complex DPY30 methylation C. elegans XX mutations XO growth development homodimer monomers WDR5 WDR-5 WDR 5 RbBP5 basal rates DPY-30L DPY30L hDPY30 SAF-19 |
14.152052839174
|
| 10628 |
EED (human recombinant)
|
|
- |
95
|
|
|
2010-12-03
|
0E-12
|
eed-human-recombinant
|
Embryonic Ectoderm Development
|
|
0E-12
|
| 10569 |
Ellagic Acid
|
|
476-66-4 |
≥95%
|
|
|
2010-10-13
|
8.133806015960
|
ellagic-acid
|
Lagistase; TBBD; Gallogen
|
polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory
Acid Benzoaric Benzoaric Acid
Acid Ellagic Ellagic Acid |
8.133806015960
|
| 11076 |
Epigenetics Screening Library (96-Well)
|
|
- |
|
|
|
2011-11-09
|
25.669649126438
|
epigenetics-screening-library-96-well
|
|
epigenetics libraries screens |
25.669649126438
|
| 13487 |
EZH1 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-14
|
0E-12
|
ezh1-polyclonal-antibody
|
|
Western blots WB immunoblotting blotting |
0E-12
|
| 10353 |
G9a (human recombinant)
|
|
- |
≥70%
|
|
|
2011-03-08
|
17.008637329521
|
g9a-human-recombinant
|
EHMT2; Euchromatic Histone-Lysine N-Methyltransferase 2; KMT1C
|
lysines methylation methyltransferases genes silencing repression proteins recombinants set domain-containing pluripotency H3K9 GLP active |
17.008637329521
|
| 10755 |
G9a-like protein (human recombinant)
|
|
- |
≥95%
|
|
|
2011-10-13
|
18.767345337971
|
g9a-like-protein-human-recombinant
|
Eu HMTase 1; EHMT1; GLP; Euchromatic Histone-Lysine N-Methyltransferase 1; KMT1D
|
lysine methylation methyltransferase genes silencing repression SET domain histones modifications GLP H3K9 BIX-01294 UNC0638 inhibitors inhibits inhibition SAR monomethylate dimethylate BIX01294 BIX 01294 UNC-0638 UNC 0638 active |
18.767345337971
|
| 10566 |
Garcinol
|
|
78824-30-3 |
≥95%
|
|
|
2011-10-25
|
9.634610820401
|
garcinol
|
Camboginol
|
inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics |
9.634610820401
|
| 10782 |
Gcn5 (human recombinant)
New
|
|
- |
≥80%
|
|
|
2011-12-05
|
24.213892198032
|
gcn5-human-recombinant
|
Lysine acetyltransferase 2A; General control of amino acid synthesis protein 5-like 2; KAT2A; STAF97
|
epigenetics modifications histones acetylation cancers GNAT N-acetyltransferases enzymes STAGA TFTC SAGA ATAC H3K14 H3K9 H3K18 H4K8 H4K16 H3 H2B KAT2B p300/CBP associated factors Spt-Ada-GCN5-aceytltransferase Ada Two-A containing CoASH Gcn-5 N-acetyltransferases enzymatic subunits complexes proteins active |
24.213892198032
|
| 10576 |
HC Toxin
|
|
83209-65-8 |
≥95%
|
|
|
2010-11-10
|
24.217044198895
|
hc-toxin
|
Toxin I (Helminthosporium carbonum)
|
inhibitors histones deacetylases HDACs cancers genes regulation regulates regulators epigenetics HC-toxins cell-permable cells permable 15-lipoxygenase-1 15-LO-1 LOs lipoxygenase 15 1 tetrapeptides peptides helminthosporium carbonums cochliobolus maize pathogens Isomerases Amino Acid
Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases |
24.217044198895
|
| 13504 |
HDAC11 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
0.365911602210
|
hdac11-polyclonal-antibody
|
Histone Deacetylase 11
|
wb western immunoblotting HDACs HAT histones antibodies peptides blots blotting |
0.365911602210
|
| 10009231 |
HDAC1 (human recombinant)
|
|
- |
>10% by SDS-PAGE
|
|
|
2006-12-06
|
28.775327141220
|
hdac1-human-recombinant
|
Histone Deacetylase 1
|
HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 active |
28.775327141220
|
| 13491 |
HDAC1 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.306104972375
|
hdac1-polyclonal-antibody
|
Histone Deactylase 1
|
HDAC-1 HDACs HDAC 1 antibodies WB western blots HATs immunoblotting blotting |
0.306104972375
|
| 10009377 |
HDAC2 (human recombinant)
|
|
- |
≥70% by SDS-PAGE
|
|
|
2006-12-06
|
23.566802079947
|
hdac2-human-recombinant
|
Histone Deacetylase 2
|
HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active |
23.566802079947
|
| 10009232 |
HDAC3/NCOR2 (human recombinant)
|
|
- |
≥50%
|
|
|
2006-12-06
|
38.905749309392
|
hdac3-ncor2-human-recombinant
|
Histone Deacetylase 3
|
HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active |
38.905749309392
|
| 13493 |
HDAC3 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-19
|
9.577400758665
|
hdac3-polyclonal-antibody
|
Histone Deacetylase 3
|
HDACs antibodies HATs histones acetyltransferase deacetylases western blotting WB IP immunoprecipation ChIP immunoblots immunoblotting blots |
9.577400758665
|
| 13494 |
HDAC4 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-17
|
0.365911602210
|
hdac4-polyclonal-antibody
|
Histone Deacetylase 4
|
WB Western blots immunoblotting IP ChIP antibodies HDACs HATs histones immunoprecipitation blotting |
0.365911602210
|
| 10009379 |
HDAC5 (human recombinant)
|
|
- |
≥90% by SDS-PAGE
|
|
|
2006-12-06
|
32.033977900551
|
hdac5-human-recombinant
|
Histone Deacetylase 5
|
HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active |
32.033977900551
|
| 10009465 |
HDAC6 (human recombinant)
|
|
- |
≥80%
|
|
|
2007-06-14
|
22.816166595834
|
hdac6-human-recombinant
|
GenBank Accession No. BC069243; Histone Deacetylase 6
|
HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 active |
22.816166595834
|
| 13499 |
HDAC6 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-14
|
4.670386740331
|
hdac6-polyclonal-antibody
|
Histone Deacetylase 6
|
HDAC-6 HDACs HDAC 6 antibodies WB western blots IP ChIP immunoblotting blotting immunoprecipitation |
4.670386740331
|
| 13500 |
HDAC7 (Phospho-Ser155) Polyclonal Antibody
|
|
- |
|
|
|
2009-07-29
|
0.778358326756
|
hdac7-phospho-ser155-polyclonal-antibody
|
Histone Deacetylase 7
|
antibodies MMP AR receptors matrix metalloproteinase androgens Nur77 histones deacetylases N-terminal immunoblotting blots western blotting WB |
0.778358326756
|
| 19380 |
HDAC8 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-04-03
|
20.800361240968
|
hdac8-human-recombinant
|
|
HDAC 8 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active |
20.800361240968
|
| 10009466 |
HDAC9 (human recombinant)
|
|
- |
≥95%
|
|
|
2007-06-14
|
16.569378453038
|
hdac9-human-recombinant
|
GenBank Accession No. NM 178423; Histone Deacetylase 9
|
histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active |
16.569378453038
|
| 600150 |
HDAC Cell-Based Activity Assay Kit
|
|
- |
|
|
|
2009-11-09
|
26.370505361597
|
hdac-cell-based-activity-assay-kit
|
Histone Deacetylase Cell-Based Activity Assay Kit
|
assays kits measuring measurement histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes fluorometric assays cancer modulators whole cells proteins lysine-specific HDAC1 homogenous inhibitor/activator TSA |
26.370505361597
|
| 13535 |
Histone H2A Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
2.045745856353
|
histone-h2a-polyclonal-antibody
|
|
H1 H2B H3 H4 histones antibodies DNA WB western blots immunoblotting ELISA enzyme-linked immunosorbent assays blotting |
2.045745856353
|
| 10261 |
Histone H2A (Xenopus recombinant)
|
|
- |
≥95%
|
|
|
2011-10-13
|
9.979322603891
|
histone-h2a-xenopus-recombinant
|
|
histones DNA nucleosome chromatin HDACs HAT H2A H2B H3 H4 octomers dimers genes transcription regulation acetylation methylation phosphorylation tetramers cores regulate ubiquitylation sumoylation biotinylation |
9.979322603891
|
| 13538 |
Histone H2B (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2009-08-04
|
1.047823204419
|
histone-h2b-c-term-polyclonal-antibody
|
|
histones antibodiesarginine lysine DNA WB western blots immunoblotting blotting |
1.047823204419
|
| 13539 |
Histone H2B (N-Term) Polyclonal Antibody
|
|
- |
|
|
|
2009-08-04
|
1.047823204419
|
histone-h2b-n-term-polyclonal-antibody
|
|
histones antibodies WB western blots immunoblotting DNA arginine lysine blotting |
1.047823204419
|
| 10262 |
Histone H2B (Xenopus recombinant)
|
|
- |
≥95%
|
|
|
2010-03-19
|
10.538693250059
|
histone-h2b-xenopus-recombinant
|
|
histones DNA nucleosomes chromatin HDAC HAT H2A H3 H4 proteins FL full legnth acetylation genes transcriptions methylation phophorylation regulation |
10.538693250059
|
| 13784 |
Histone H3.3 Polyclonal Antibody
|
|
- |
|
|
|
2010-05-07
|
5.939042357274
|
histone-h3-3-polyclonal-antibody
|
H3.3B; H3.3A; H3F3A; H3F3B
|
histones antibodies immunohistochemistry IHC western blotting blots immunoblotting WB H2A H2B H3 H4 H-2A H-2B H-3 H-4 H 2A 2B 3 4 proteins nuclear DNA cells biology chromatin research epigenetics genes regulation modification histones |
5.939042357274
|
| 10263 |
Histone H3 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-03-22
|
33.692926130550
|
histone-h3-human-recombinant
|
|
histones DNA nucleosomes chromatin HDAC HAT H2A H2B H4 acetylation methylation phosphorylation |
33.692926130550
|
| 13540 |
Histone H3 (Phospho-Ser28) Monoclonal Antibody (Clone 117C826)
|
|
- |
|
|
|
2009-08-10
|
1.507163904235
|
histone-h3-phospho-ser28-monoclonal-antibody-clone-117c826
|
PHH3
|
H1 H2B H3 H4 histones antibodies WB western blots immunoblotting serine phosphos phosphorylation blotting |
1.507163904235
|
| 10264 |
Histone H4 (human recombinant)
|
|
- |
>95%
|
|
|
2010-09-07
|
8.883149171271
|
histone-h4-human-recombinant
|
H4; Histone H4
|
|
8.883149171271
|
| 13543 |
Histone H4 Polyclonal Antibody
|
|
- |
|
|
|
2009-08-10
|
0.311850828729
|
histone-h4-polyclonal-antibody
|
|
antibodies H1 H2A H2B H3 amino acids WB western blots immunblotting blotting |
0.311850828729
|
| 13295 |
HNHA
|
|
926908-04-5 |
≥98%
|
|
|
2009-09-03
|
23.011531893520
|
hnha
|
Histone Deacetylase Inhibitor VI
|
inhibitors inhibits inhibition histones deacetylase HDACs cancers fibrosarcoma HT1080 cells hyperacetylation p21 genes expressions transcription cycles arrest tumor growth murine xenograph human umbilical vein endothelial HUVECs tubes formation migration vascular endothelial factors VEGF retinal neovascularization angiogenesis |
23.011531893520
|
| 13782 |
I2PP2A/SET Polyclonal Antibody
|
|
- |
|
|
|
2010-05-10
|
2.167182320442
|
i2pp2a-set-polyclonal-antibody
|
Template-Activating Factor I; Inhibitor of granzyme A-activated DNase; Phosphatase 2A Inhibitor; PHAPII
|
antibodies WB western blots blotting immunoblotting histones INHAT1 INHAT 1 coactivators transcription cells TAF1α TAF 1α TAF1β TAF 1β SETs INHAT-1 protein SET SET/I2PP2A TAF-1 TAF 1 TAF1 TAF-1beta TAF-1.beta. IGAAD |
2.167182320442
|
| 11572 |
IOX1
New
|
|
5852-78-8 |
≥97%
|
|
|
2012-05-09
|
95.770095150398
|
iox1
|
|
hypoxia 2-oxoglutarate Fe 2OG ferrous iron-dependent oxygenases collagen histones demethylation inhibitors inhibits inhibition H3K9me3 JMJD2A JMJD2E enzymes lipids metabolism nucleic acid diseases cancers oxygenases PHF8 PHD2 FIH |
95.770095150398
|
| 10641 |
JGB1741
Exclusive
|
|
1256375-38-8 |
≥98%
|
|
✓ |
2011-06-20
|
17.811325966850
|
jgb1741
|
ILS-JGB-1741
|
inhibitors SIRT1 breasts cancers cells proliferation apoptosis p53 histones acetylation genes energy homeostasis regulation deacetylases sirtuins NAD+ inhibits inhibition SIRT2 SIRT3 ILS JGB 1,741 1741 SIRTs JGB-1741 JGB-1,741 |
17.811325966850
|
| 10336 |
JMJD2A (human recombinant)
|
|
- |
≥95%
|
|
|
2010-12-01
|
17.414083026396
|
jmjd2a-human-recombinant
|
JHDM3A; KDM4A; Jumonji Domain Containing 2A
|
lysine (K)-specific demethylase 4A Epigenetics Histone Demethylase chromatin regulator dioxygenase JmjC active |
17.414083026396
|
| 700360 |
JMJD2A Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2010-05-25
|
19.047282813814
|
jmjd2a-inhibitor-screening-assay-kit
|
Jumonji Domain Containing 2A Inhibitor Screening Assay Kit
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated |
19.047282813814
|
| 10382 |
JMJD2A Polyclonal Antibody
|
|
- |
|
|
|
2010-04-15
|
13.421713730304
|
jmjd2a-polyclonal-antibody
|
Lysine-Specific Demethylase 4A; KDM4A; Jumonji Domain Containing 2A
|
lysine histones amino acids western blots blotting WB flow cytometry FC immunocytochemistry ICC cells lysate tissues control jumonjis JMJD2D |
13.421713730304
|
| 11299 |
JMJD2A-Strep tagged (human recombinant)
Exclusive New
|
|
- |
≥95%
|
|
✓ |
2012-05-08
|
110.723606945540
|
jmjd2a-strep-tagged-human-recombinant
|
KDM4A; Jumonji Domain Containing 2A; JHDM3A
|
JMJD2A Jumonji domain demethylase epigenetics FDH KDM4Atrimethylllysine-specific JmjC protein hydroxylase Strep-Tactin StrepTactin Strep Tactin |
110.723606945540
|
| 10335 |
JMJD2D (human recombinant)
|
|
- |
≥75%
|
|
|
2011-02-09
|
15.302862014869
|
jmjd2d-human-recombinant
|
Jumonji Domain Containing 2D; KDM4D; Lysine-Specific Demethylase 4D
|
epigenetics histones demethylases chromatin regulators dioxygenases JmjC proteins jumanjis active |
15.302862014869
|
| 700370 |
JMJD2D Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2010-05-25
|
19.603553147282
|
jmjd2d-inhibitor-screening-assay-kit
|
Jumonji Domain Containing 2D Inhibitor Screening Assay Kit
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation FLJ10251 replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated |
19.603553147282
|
| 10383 |
JMJD2D Polyclonal Antibody
|
|
- |
|
|
|
2010-04-16
|
23.467726140179
|
jmjd2d-polyclonal-antibody
|
Jumonji Domain Containing 2D; Lysine-Specific Demethylase 4D; KDM4D
|
lysine histones amino acids western blots blotting WB flow cytometry FC immunocytochemistry ICC cells lysate tissues control jumonjis JMJD2A |
23.467726140179
|
| 11300 |
JMJD2D-Strep tagged (human recombinant)
Exclusive New
|
|
- |
≥70%
|
|
✓ |
2012-05-08
|
113.753599052880
|
jmjd2d-strep-tagged-human-recombinant
|
KDM4D; Lysine-specific Demethylase 4D; Jumonji Domain Containing 2D
|
JMJD2D Jumonji domain demethylase epigenetics FDH KDM4D JmjC proteins hydroxylase Strep Tactin StrepTactin Strep-Tactin |
113.753599052880
|
| 11237 |
JMJD2E-Strep tagged (human recombinant)
Exclusive New
|
|
- |
≥75%
|
|
✓ |
2012-05-08
|
124.786284837323
|
jmjd2e-strep-tagged-human-recombinant
|
Jumonji Domain Containing 2E; KDM4D-Like
|
JMJD2D Jumonji domain demethylase epigenetics FDH KDM4D JmjC protein hydroxylase Strep-Tactin Strep Tactin StrepTactin KDM4DL |
124.786284837323
|
| 13787 |
JMJD6 Peptide Affinity-Purified Polyclonal Antibody
|
|
- |
|
|
|
2010-05-13
|
4.662667001506
|
jmjd6-peptide-affinity-purified-polyclonal-antibody
|
Jumonji Domain Containing 6; PTDSR
|
antibodies western blots blotting immunoblotting nuclear protein JMJC domains histones H3 H4 H 3 H 4 H-3 H-4 chromatin epigenetics genes regulations modification |
4.662667001506
|
| 11232 |
(−)-JQ1
Exclusive New
|
|
1268524-71-5 |
≥98%
|
|
✓ |
2012-04-23
|
107.848419726214
|
-jq1
|
|
BET bromodomain inhibitors inhibits inhibition BRD4 BRD2 transcription cancers extra terminal domains proteins BRD3 cells inflammatory inflammation genes expression mitosis viral viruses histones chromatin JQ 1 JQ-1 (±)-JQ1 ±-JQ1 |
107.848419726214
|
| 11187 |
(+)-JQ1
Exclusive New
|
|
1268524-70-4 |
≥98%
|
|
✓ |
2012-04-23
|
220.321955079750
|
-jq1
|
|
BET bromodomain inhibitors inhibits inhibition BRD4 BRD2 transcription cancers JQ-1 JQ 1 extra terminal domains BRD3 cells genes expression inflammatory inflammation viral viruses mitosis histones chromatin (±)-JQ1 ±-JQ1 10741 |
220.321955079750
|
| 10245 |
LSD1 (human recombinant)
|
|
- |
≥50%
|
|
|
2009-06-03
|
5.453445769118
|
lsd1-human-recombinant
|
AOF2; NPAO; Lysine-Specific Demethylase 1; BHC110; p110b; KDM1
|
recombinant humans E.coli histones tumors suppressor CoREST lysine specific demethylase 1 proteins enzymes active |
5.453445769118
|
| 700120 |
LSD1 Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2008-10-16
|
24.063191420214
|
lsd1-inhibitor-screening-assay-kit
|
Lysine-Specific Demethylase 1
|
lysines 4 demethylases histones residues repression transcription chromosomal DNA chromosomes inhibits inhibitors inhibition tumors suppressors activity cells cycles progression cancers fluorescent fluorescence enzymes enzymatic reactions H2O2 hydrogens peroxides peptides N-terminal tails H3 horseradish peroxidases ADHP resorufins assays |
24.063191420214
|
| 13554 |
LSD1 Polyclonal Antibody (aa 100-150)
|
|
- |
|
|
|
2009-08-10
|
0.158195211786
|
lsd1-polyclonal-antibody-aa-100-150
|
Amine Oxidase (flavin containing) Domain 2
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 AOF2 amine oxidase flavin containing domain 2 peptide affinity blotting |
0.158195211786
|
| 13553 |
LSD1 Polyclonal Antibody (aa 400-450)
|
|
- |
|
|
|
2009-08-10
|
0.158195211786
|
lsd1-polyclonal-antibody-aa-400-450
|
|
antibodies WB western blots immunoblotting lysine histones demethylase FAD-binding SWIRM domains blotting |
0.158195211786
|
| 13486 |
LSD1 Polyclonal Antibody (aa 450-500)
|
|
- |
|
|
|
2009-08-11
|
0.135595895816
|
lsd1-polyclonal-antibody-aa-450-500
|
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 blotting |
0.135595895816
|
| 13555 |
LSD1 Polyclonal Antibody (aa 800-850)
|
|
- |
|
|
|
2009-08-13
|
0.158195211786
|
lsd1-polyclonal-antibody-aa-800-850
|
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 immunohistochemistry IHC paraffin AOF2 amine oxidase flavin containing domain 2 blotting |
0.158195211786
|
| 13174 |
M 344
|
|
251456-60-7 |
≥98%
|
|
|
2009-07-24
|
25.973145718231
|
m-344
|
D237; Histone Deacetylase Inhibitor III; MS 344
|
HDACs inhibitors inhibits inhibitions histones deacetylases HDAC1 HDAC6 cancers squamous carcinoma radiation cells cycles arrest apoptosis endometrial ovarian M344 MS344 M-344 MS-344 |
25.973145718231
|
| 13778 |
Metastasis Associated 1 Family Member 2 Polyclonal Antibody
|
|
- |
|
|
|
2010-05-04
|
8.700276243093
|
metastasis-associated-1-family-member-2-polyclonal-antibody
|
p53 Target Protein in Deacetylase Complex; MTA2; MTA-L1 Protein; PID
|
WB IHC western blotting blots immunoblotting immunohistochemistry MTA-2 MTA 2 MTA-1 MTA 1 MTA-3 MTA 3 HDAC2 HDAC-2 HDAC 2 HDAC1 HDAC-1 HDAC 1 proteins chromatin deacetylase activity activities northern p53 |
8.700276243093
|
| 13727 |
Methylated Lysine Polyclonal Antibody
|
|
- |
|
|
|
2009-12-04
|
9.272799263351
|
methylated-lysine-polyclonal-antibody
|
|
WB western blots blotting immunoblotting IP immunoprecipitation ELISA antibodies SUV39H1 lysines proteins histones H3 genes expressions immunohistochemistry IHC |
9.272799263351
|
| 13728 |
Methylated Lysine Polyclonal Antibody-biotin
|
|
- |
|
|
|
2009-12-04
|
6.933941068139
|
methylated-lysine-polyclonal-antibody-biotin
|
|
WB western blots blotting immunoblotting IP immunoprecipitation ELISA antibodies SUV39H1 lysines proteins histones H3 |
6.933941068139
|
| 13729 |
Methylated Lysine Polyclonal Antibody HRP Conjugate
|
|
- |
|
|
|
2009-12-04
|
6.933941068139
|
methylated-lysine-polyclonal-antibody-hrp-conjugate
|
|
WB western blots blotting immunoblotting ELISA antibodies SUV39H1 lysines proteins histones H3 |
6.933941068139
|
| 700140 |
Methyltransferase Colorimetric Assay Kit
|
|
- |
|
|
|
2009-04-07
|
30.225331001137
|
methyltransferase-colorimetric-assay-kit
|
MT Colorimetric Assay Kit
|
assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymatic cofactors AdoMet donor modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine |
30.225331001137
|
| 700150 |
Methyltransferase Fluorometric Assay Kit
|
|
- |
|
|
|
2009-04-08
|
26.105699252585
|
methyltransferase-fluorometric-assay-kit
|
MT Fluorometric Assay Kit
|
assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis proteins repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymes enzymatic cofactors AdoMet donor proteins modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine |
26.105699252585
|
| 10658 |
MLL1 (human recombinant)
New
|
|
- |
≥95%
|
|
|
2011-12-21
|
0.478496503496
|
mll1-human-recombinant
|
Lysine Methyltransferase 2A; ALL1; Mixed Lineage Leukemia 1; HRX; KMT2a
|
epigenetics methyltransferase histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY30 mixed lineage leukemia methylation lysine HOX Pol II WAR c-terminal SET1 WIN binds binding DPY-30 WARD genomic |
0.478496503496
|
| 10756 |
MLL1/WAR complex (human recombinant)
New
|
|
- |
≥90%
|
|
|
2012-01-04
|
14.152052839174
|
mll1-war-complex-human-recombinant
|
Mixed-Lineage Leukemia-1; MLL Core Complex
|
epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin active |
14.152052839174
|
| 10945 |
MLL1/WARD complex (human recombinant)
New
|
|
- |
≥90%
|
|
|
2012-01-04
|
16.762033767337
|
mll1-ward-complex-human-recombinant
|
Mixed-Lineage Leukemia-1; KMT2A; MLL Core Complex
|
epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin WAR active |
16.762033767337
|
| 13284 |
MS-275
|
|
209783-80-2 |
≥98%
|
|
|
2009-11-05
|
37.997177716390
|
ms-275
|
Entinostat; SNDX 275
|
inhibitors histone deacetylases HDACs HDAC1 HDAC3 HDAC8 cyclin-dependent kinase inhibitor 1A p21 CIP1 WAF1 cell growth differentiation tumors cancers apoptosis adriamycin PARP Hsp90 ms275 MS 27-275 SNDX-275 SNDX275 MS27275 |
37.997177716390
|
| 11633 |
NCOR2/SMRT (human recombinant)
New
|
|
- |
≥60%
|
|
|
2012-04-09
|
85.995493155963
|
ncor2-smrt-human-recombinant
|
TRAC; T3 Receptor-Associating Factor; Nuclear Receptor Corepressor 2; Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor; CTG Repeat Protein 26; SMRT; SMAP270; Thyroid-Retinoic-Acid-Receptor-Associated Corepressor
|
epigenetics histones deacetylases transcriptional regulations corepressor co-repressor complexes metabolism HDACs HDAC3 class I HDAC yeast Rpd DAD E2F TFIIE TFIIF NF-κB p300 Stat3 p53 retinoblastoma protein Rb protein differentiation cell death angiogenesis inflammation cancers inflammatory diseases |
85.995493155963
|
| 10758 |
NSD2 (human recombinant)
New
|
|
- |
≥90%
|
|
|
2012-02-01
|
5.306521739130
|
nsd2-human-recombinant
|
Histone-lysine N-methyltransferase NSD2 isoform 1; MMSET; TRX5; Wolf-Hirschorn Syndrome Candidate 1; Nuclear Receptor SET domain-containing protein 2; Multiple myeloma SET domain-containing protein; Protein trithorax-5; WHSC1; KIAA1090
|
NSD2 SET-Domains Lysine methyltransferases chromatin WHSC1 MMSET WHSCH1-like multiple myeloma translocations histones H3 H4 H3K36 H4K44 H4K20 53BP1 dimethylation DNA damages NSDs NSD-2 active |
5.306521739130
|
| 13176 |
Oxamflatin
|
|
151720-43-3 |
≥95%
|
|
|
2010-11-16
|
28.367523020257
|
oxamflatin
|
Metacept 3
|
HDACs histones deacetylases genes expressions morphology motility apoptosis cells cycles cancers reducing reduction proliferation Acids Hydroxamic
Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid |
28.367523020257
|
| 10500 |
PAD4 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-05-27
|
68.342983425414
|
pad4-human-recombinant
|
Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4
|
guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase active |
68.342983425414
|
| 10009115 |
pCAF Histone Acetyltransferase
|
|
- |
≥95%
|
|
|
2006-10-18
|
20.201293020038
|
pcaf-histone-acetyltransferase
|
HAT; p300/(CREB binding protein) Associated Factor
|
proteins binding GCN5 nuclear acetyltransferases C-terminal C-terminus acetyl-lysine N-terminal N-terminus histones H3 H4 transcriptional activators MyoD E2F1 p53 acetylates PTEN K125 K128 catalytic cleft in vivo enzymes cancers active |
20.201293020038
|
| 13212 |
Pimelic Diphenylamide 106
Exclusive
|
|
937039-45-7 |
≥98%
|
|
✓ |
2009-09-30
|
18.483024134922
|
pimelic-diphenylamide-106
|
|
inhibitors inhibits inhibitions class I histone deacetylases HDACs SAHA HDAC1 HDAC2 HDAC3 HDAC8 II HDAC4 HDAC5 HDAC7 benzamides friedrich ataxia huntington disease |
18.483024134922
|
| 11209 |
PRDM9 (human recombinant)
Exclusive New
|
|
- |
≥65%
|
|
✓ |
2012-01-11
|
24.814814814814
|
prdm9-human-recombinant
|
PR Domain-containing Protein 9; MSBP3; ZNF899; PFM6; Meisetz
|
histones methyltransferases zinc-fingers hotspots recombination genomes genetics meiosis trimethylation H3K4 nucleosomes PR/SET HTMase c-terminal C2-H2 PR domain zinc finger protein 9 |
24.814814814814
|
| 10350 |
PRMT1 (human recombinant)
|
|
- |
≥80%
|
|
|
2011-01-25
|
112.131740860628
|
prmt1-human-recombinant
|
Protein Arginine Methyltransferase 1
|
PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged active |
112.131740860628
|
| 10750 |
PRMT4 (human recombinant)
New
|
|
- |
≥70%
|
|
|
2011-12-21
|
9.138927255985
|
prmt4-human-recombinant
|
Protein Arginine Methyltransferase 4; CARM1; Coactivator-associated Arginine Methyltransferase 1
|
PRMT arginine methyltransferases epigenetics PRMT4 CARM1 SAM MMA aDMA Arg-17 Arg-26 proteins enzymes catalytic domains S-adenosyl-L-methionine histones H3 binding binds p160 SRC-1 SRC1 GRIP1 TIF2 pCIP RAC3 ACTR AIB1 TRAM1 nuclear receptors phosphorylation Ser217 hormones regulation lipids metabolism ω-NG,NG-dimethylarginine ω-NG-monomethylarginine active |
9.138927255985
|
| 13552 |
PRMT4 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0E-12
|
prmt4-polyclonal-antibody
|
CARM1; Protein Arginine Methyltransferase 4
|
antibodies WB western immunoblotting blots coactivator associated arginine methyltransferase 1 steroids receptors SRC proteins co-activators blotting |
0E-12
|
| 10752 |
PRMT6 (human recombinant)
New
|
|
- |
≥80%
|
|
|
2012-01-24
|
8.669677008074
|
prmt6-human-recombinant
|
Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6
|
PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a active |
8.669677008074
|
| 10947 |
RbBP5 (human recombinant)
New
|
|
- |
≥90%
|
|
|
2012-01-06
|
14.152052839174
|
rbbp5-human-recombinant
|
SWD1, Set1c WD40 repeat protein, homolog; Retinoblastoma binding Protein 5; RBQ3
|
epigenetics methyltransferases histones H3K4 genes regulation MLL proteins complex subunits nuclear WD40 domains tumors supressors RB cells proliferation E1A SET1 lysine MLL1 MLL1-4 dimethylation trimethylation H3 H3K4me2/me3 retinoblastoma-binding protein RBQ-3 RBBP-5 RBBP5 |
14.152052839174
|
| 10765 |
RIZ1 (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-05-02
|
76.169567428508
|
riz1-human-recombinant
|
KMT8; Retinoblastoma Protein-interacting Zinc Finger Protein; PR Domain Zinc Finger Protein 2; PRDM2
|
epigenetics cancer Histone H3K9 PR Domain Zinc-Finger histones methyltransferases RIZ-1 RIZ 1 SAM-dependent RIZs tumor suppressor apoptosis methylation |
76.169567428508
|
| 10009929 |
SAHA
|
|
149647-78-9 |
≥98%
|
|
|
2007-08-07
|
111.847118621265
|
saha
|
Vorinostat; Suberoylanilide Hydroxamic Acid; Zolinza™
|
HDACs inhibitors cancers inhibits inhibition |
111.847118621265
|
| 10675 |
SAHA-BPyne
Exclusive
|
|
930772-88-6 |
≥98%
|
|
✓ |
2011-07-26
|
34.859079189686
|
saha-bpyne
|
Suberoylanilide Hydroxamic Acid-BPyne
|
click chemistry SAHA HDACs inhibitors inhibits inhibition probes SAHA BPyne epigenetics chromatin histones modification |
34.859079189686
|
| 10443 |
SB 939
New
|
|
929016-96-6 |
≥98%
|
|
|
2012-02-06
|
7.126284948937
|
sb-939
|
Pracinostat
|
inhibits inhibitions inhibitor HDACs pan-HDAC panHDAC SB939 SB-939 histones deacetylase proliferation voronistat cancers tumors SAHA ovarian A2780 colon COLO205 HCT-116 prostate PC-3 |
7.126284948937
|
| 10572 |
Scriptaid
|
|
287383-59-9 |
≥98%
|
|
|
2010-09-27
|
43.534185082873
|
scriptaid
|
GCK 1026
|
histones deacetylases HDACs inhibitors inhibition inhibits cancers cloning cells arrest somatic nuclear transfers Scriptides trichostatin A mouse inbred strains somaic GCK-1026 GDK1026 hydroxylamines
|
43.534185082873
|
| 13780 |
SET7/9 (FL) Polyclonal Antibody
|
|
- |
|
|
|
2010-03-08
|
6.526586863106
|
set7-9-fl-polyclonal-antibody
|
SET Domain-Containing Protein; KMT7; SETD7/9
|
antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting |
6.526586863106
|
| 10320 |
SET7/9 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-08-11
|
24.024535383748
|
set7-9-human-recombinant
|
KMT7; SETD7/9; SET Domain-containing Protein 7/9
|
SET-7/9 SET 7/9 7 9 recombinant His-tagged proteins SETs methylation methyltransferase active |
24.024535383748
|
| 700270 |
SET7/9 Methyltransferase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-12-04
|
24.872556970425
|
set7-9-methyltransferase-inhibitor-screening-assay-kit
|
|
methyltransferases SET Domain-containing Protein 7/9 lysines 7 KMT7 methylation signal transduction biosynthesis proteins repair genes silencing chromatins S-adenosylmethionine SAM AdoMet methyl donors Alzheimer's depression Parkinson's Diseases multiple sclerosis liver cancers substrates histones histone 3 lysine residue 4 H3K4 p53 transcription factors TAF10 mono-methylated mono-methylase DNA damage acetylation human tumorigenesis inhibitors acceptor peptides S-adenosylhomocysteine S-ribosylhomocysteine adenine nucleosidase hypoxanthine deaminase urate hydrogen peroxide H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin fluorescence measures measurement assays kits |
24.872556970425
|
| 13731 |
SET7/9 Polyclonal Antibody
|
|
- |
|
|
|
2009-11-25
|
35.149309392265
|
set7-9-polyclonal-antibody
|
|
antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting |
35.149309392265
|
| 600490 |
SET7/9 SAM-Screener Assay Kit
New
|
|
- |
|
|
|
2011-12-21
|
41.633066544674
|
set7-9-sam-screener-assay-kit
|
SET7/9 SAM-Binding Site Inhibitor Screening
|
kits assays measures measurements chromatins posttranslational modifications histones DNA deoxyribonucleic acids lysines methylations epigenetics regulations genomes mono-methyltransferases MTs domains S-adenosyl-L-methionines SAM AdoMet co-factors epsilons amino groups Dot1 KMT7 domain-containing non-histones H3 TAF10 p53 viral Tat estrogens receptors alpha .alpha. α substrates humans diseases catalytic catabolism fluorescence EpiTrek polarizations fluorescent probes binding pockets endogenous cofactors sinefungin peptides high-throughput |
41.633066544674
|
| 10319 |
SET8 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-01-07
|
16.373424505296
|
set8-human-recombinant
|
SETD8; SET domain-containing (lysine methyltransferase) 8; KMT5a; PR-Set7
|
SET-8 SET 8 recombinant His-tagged proteins SETs methylation methyltransferase MTs domain containing active |
16.373424505296
|
| 10767 |
SETD2 (human recombinant)
New
|
|
- |
≥95%
|
|
|
2012-01-19
|
10.685672191528
|
setd2-human-recombinant
|
p231HBP; Huntington Interacting Protein B; KMT3A; HYPB
|
epigenetics histones methyltransferases SET-domains containing SETD-2 SETD 2 huntingtin interacting proteins b HYBP trimethylation H3K36me3 mouse fibroblasts cells mono-methylation di-methylation WW hyperphosphorylation RNA polymerase II regulation diseases |
10.685672191528
|
| 13277 |
(S)-HDAC-42
|
|
935881-37-1 |
≥95%
|
|
|
2009-12-03
|
27.127075354659
|
-s-hdac-42
|
AR42
|
histones deacetylases HDACs cancers inhibitors prostate p21 Akt Bcl-XL tumors inhibition inhibits OSU-HDAC-42 |
27.127075354659
|
| 10010401 |
SIRT1 Direct Fluorescent Screening Assay Kit
|
|
- |
|
|
|
2008-02-26
|
51.236933701657
|
sirt1-direct-fluorescent-screening-assay-kit
|
|
SIRT 1 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human homologs yeast SIR2 silent information regulators 2 tumors cancers suppressors inhibits inhitors inhibition apoptosis screening fluorescence activators fluorescent fluorometric |
51.236933701657
|
| 10010991 |
SIRT1 FRET-Based Screening Assay Kit
|
|
- |
|
|
|
2008-02-19
|
20.010414364640
|
sirt1-fret-based-screening-assay-kit
|
|
SIRT 1 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human homologs yeast SIR2 silent information regulators 2 tumors cancers suppressors inhibits inhitors inhibition apoptosis screening fluorescence activators fluorescent fluorometric |
20.010414364640
|
| 10011190 |
SIRT1 (human recombinant)
|
|
- |
≥60%
|
|
|
2008-09-24
|
19.030764272559
|
sirt1-human-recombinant
|
Silent Information Regulator 2; Sirtuin 1; SIR2-like Protein 1; SIR2L1; NAD-dependent Deacetylase 1
|
SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 1 SIR2alpha sirtuin type 1 active |
19.030764272559
|
| 700280 |
SIRT2 Direct Fluorescent Screening Assay Kit
|
|
- |
|
|
|
2009-12-10
|
40.755135213724
|
sirt2-direct-fluorescent-screening-assay-kit
|
|
Nucleosomes chromosomal deoxyribonucleases DNA histones H2A H2B H3 H4 octameric cores transcription amino termini acetylation phosphorylation methylation ε-amino lysines acetyltransferases HATs chromatins genes activation deacetylases HDACs catalyzes hydrolytic acetyls sirtuins trichostatins A-insensitive lysyl-deacetylases class III catalyzes deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ human SIRT1 SIRT2 SIRT3 SIRT4 SIRT5 SIRT6 SIRT7 cytoplasmic proteins H4 lysine-16 lysine-40 α-tubulin a-tubulin alpha-tubulin HDAC6 microtubules mitotic chromosomal hyperpolid cells tissues skeletal muscle heart oligodendroglia brain tumor suppressor gliomas Down-regulation gene chromosomal region diagnostic marker fluorescence-based inhibitors activators p53 Gln-Pro-Lys-Lys(ε-acetyl)-AMC recombinant NAD+ fluorescent fluorescence kits assays measures measurement |
40.755135213724
|
| 10011191 |
SIRT2 (human recombinant)
|
|
- |
≥90%
|
|
|
2009-07-31
|
16.713987108655
|
sirt2-human-recombinant
|
Silent Information Regulator 2; Sirtuin 2; SIR2-like Protein 2; NAD-dependent Deacetylase 2; SIR2L2
|
SIRT 2 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers His-tagged His tag sirtuin silent mating type information regulation 2 homolog 2 sirtuin type 2 active |
16.713987108655
|
| 10011194 |
SIRT3 (human recombinant)
|
|
- |
≥90%
|
|
|
2008-12-15
|
25.532397790055
|
sirt3-human-recombinant
|
SIR2L3; Mitochondrial Nicotinamide Adenine Dinuclear-dependent Deacetylase; SIR2-like Protein 3; NAD-dependent Deacetylase 3; Silent Information Regulator 3; Sirtuin 3
|
SIRT 3 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 3 sirtuin type 3 sir2-like 3 active |
25.532397790055
|
| 10317 |
SIRT4 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-01-06
|
9.452173112338
|
sirt4-human-recombinant
|
Sirtuin 4; Silent Information Regulator 4; SIR2L4; SIR2-like Protein 4; NAD-dependent ADP-ribosyltransferase Sirtuin 4
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidines HDACS histone decatylases GDH glutamate dehydrogenase sirtuin silent mating type information regulation 2 homolog 4 sirtuin type 4 |
9.452173112338
|
| 10318 |
SIRT5 (human recombinant)
|
|
- |
≥90%
|
|
|
2009-07-31
|
18.494220994474
|
sirt5-human-recombinant
|
Silent Information Regulator 5; Sirtuin 5; SIR2L5; SIR2-like Protein 5; NAD-dependent Deacetylase 5
|
SIRTs proteins HDACs CSP1 GST-tagged silent mating type information regulation 2 homolog 5 sirtuin type 5 |
18.494220994474
|
| 10315 |
SIRT6 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-07-31
|
16.179944751381
|
sirt6-human-recombinant
|
Sirtuin 6; NAD-dependent Deacetylase 6; Silent Information Regulator 6; SIR2L6; SIR2-like Protein 6
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidine silent mating type information regulation 2 homolog 6 sirtuin type 6 active |
16.179944751381
|
| 10316 |
SIRT7 (human recombinant)
|
|
- |
≥85%
|
|
|
2009-12-22
|
13.922508287293
|
sirt7-human-recombinant
|
SIR2L7; Sirtuin 7; Silent Information Regulator 7; SIR2-like protein 7; NAD-dependent deacetylase 7
|
SIRTs Sirtuins HDACs proteins His-tagged hexahistidine histone deacetylases silent mating types information regulators 2 homologs |
13.922508287293
|
| 13477 |
SIRT7 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-28
|
16.168250460404
|
sirt7-polyclonal-antibody
|
Silent Information Regulator 7; Sirtuin 7; Sir2
|
antibodies SIRTs Sir2-like proteins WB western immunoblotting blots blotting sirtuins regulators |
16.168250460404
|
| 13168 |
Splitomicin
|
|
5690-03-9 |
≥98%
|
|
|
2010-07-15
|
13.082355958958
|
splitomicin
|
1-Naphthalenepropanoic Acid
|
sirtuins Sir2p Sir-2p Sir 2p SIR2 NAD NAD+-dependent NAD-dependent dependent histone deacetylase activity activities genes regulations lifespan life-span life span yeast expression DNA replication inhibitor inhibits inhibition Hst1 Hst-1 Hst 1 HDACs chromatin research epigenetics regulation modification Sirs small molecules Pyrones |
13.082355958958
|
| 10574 |
Suberohydroxamic Acid
|
|
38937-66-5 |
≥98%
|
|
|
2010-09-28
|
21.781184392264
|
suberohydroxamic-acid
|
SBHA; Suberic bis-Hydroxamic Acid
|
histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid
Warner Lambert Brand of Mefenamic Acid
Pharmascience Brand of Mefenamic Acid
First Horizon Brand of Mefenamic Acid
Parke Davis Brand of Mefenamic Acid
Farmasierra Brand of Mefenamic Acid
Ashbourne Brand of Mefenamic Acid
Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid
Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid
Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid
Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid
Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid
PMS Mefenamic Acid
Acid Mefenaminic
Mefenaminic Acid
Acid Mefenamic Mefenamic Acid Forte Ponstan
Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac |
21.781184392264
|
| 10763 |
SUV4-20H1 (human recombinant)
|
|
- |
≥60%
|
|
|
2011-07-13
|
32.081229281768
|
suv4-20h1-human-recombinant
|
KMT5B; Suppressor of Variegation 4-20 Homolog 1; Lysine N-methyltransferase 5B
|
methyltranferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysines methylation epigenetics genes regulations KMT5B trimethylation H4K20 GRIP1 KMT5C KMT-5B KMT-5C KMTs active |
32.081229281768
|
| 10764 |
SUV4-20H2 (human recombinant)
|
|
- |
≥95%
|
|
|
2011-06-06
|
32.572251381215
|
suv4-20h2-human-recombinant
|
Suppressor of Variegation 4-20 Homolog 2; KMT5C
|
methyltransferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysine methylation epigenetics genes regulation SETD8 Pr-SET7 SUV420H2 SUV-420H2 SUV 420H2 SUV420H1 SUV-420H1 SUV 420H1 active |
32.572251381215
|
| 10228 |
TAF 10 Peptide
|
|
- |
|
|
|
2009-03-23
|
14.982662983425
|
taf-10-peptide
|
TAFII30; TATA Box Binding Protein (TBP)-Associated Factor; TBP-Associated Factor 10; TAF10 RNA Polymerase II
|
proteins RNA polymerase II |
14.982662983425
|
| 13788 |
TBLR1 Polyclonal Antibody
|
|
- |
|
|
|
2010-05-24
|
11.767955801105
|
tblr1-polyclonal-antibody
|
Transducin β-Like 1X-Related Protein 1; F-Box-Like/WD Repeat-Containing Protein
|
antibodies WB western blots blotting immunoblotting TBLR-1 TBLR 1 N-CoR NCoR N CoR SMRT nuclears receptors corepressors retinoid thyroid hormones HDACs histones deacetylases HDAC3 HDAC-3 3 TBL1X1R |
11.767955801105
|
| 10783 |
TIP60 (human recombinant)
New
|
|
- |
≥80%
|
|
|
2012-02-27
|
13.967022262195
|
tip60-human-recombinant
|
Hs.6364; HIV-1 Tat Interacting Protein 60 kDa; Esa1; HTATIP; cPLA(2) Interacting Protein; KAT5; PLIP
|
histones acetyl transferases HATs KAT5 KATs lysine acetyltransferases Tip-60 epigenetics histones modifications MYST Ataxia Telangiectasia Mutants p400 complex γH2AX iTIP60 Tip-60 |
13.967022262195
|
| 13789 |
TIP60 Polyclonal Antibody
|
|
- |
|
|
|
2010-05-24
|
7.423494475138
|
tip60-polyclonal-antibody
|
KAT5; Lysine Acetyltransferase 5
|
antibodies TIP-60 TIP 60 TIPs HDACs western blots blotting immunblotting immunohistochemsitry IHC histones DAN proteins transcription factors |
7.423494475138
|
| 10559 |
Tubastatin A (trifluoroacetate salt)
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-02-08
|
38.988967541436
|
tubastatin-a-trifluoroacetate-salt
|
|
HDAC6 inhibitors histones deacetylases neuroprotection neurons epigenetics TFA inhibition inhibited neuronal protection α-tubulin alpha tubulin .alpha.tubulin a-tubulin tubastatin-A Acids Hydroxamic Hydroxamic Acids
Acid Hydroxamic Hydroxamic Acid
|
38.988967541436
|
| 13631 |
UNC0224
Exclusive
|
|
1197196-48-7 |
≥98%
|
|
✓ |
2010-08-10
|
21.928835529111
|
unc0224
|
|
inhibitors inhibits inhibition histones methyltransferases genes regulation regulator chromatin remodeling UNC 0224 UNC-0224 G9a SET8 SET7/9 lysine HMTase |
21.928835529111
|
| 10582 |
UNC0321 (trifluoroacetate salt)
Exclusive
|
|
- |
≥95%
|
|
✓ |
2011-03-15
|
13.187769964842
|
unc0321-trifluoroacetate-salt
|
|
methyltransferases inhibitors histones genes regulation chromatin remodeling G9a HMTase inhibited inhibition potent selective MT SET7/9 SET8 PRMT3 JMJD2E |
13.187769964842
|
| 10734 |
UNC0638
|
|
1255580-76-7 |
≥98%
|
|
|
2011-05-03
|
22.094889502762
|
unc0638
|
|
methyltransferases inhibitors histones genes regulation chromatin remodeling inhibited inhibition G9a MT GLP PRMT 3 SUV39H2 SET7/9 SET8 inhibits H3K9 dimethylation MDA-MB231 |
22.094889502762
|
| 10774 |
UTX (human recombinant)
|
|
- |
≥85%
|
|
|
2011-05-24
|
19.139403519541
|
utx-human-recombinant
|
Ubiquitously Transcribed Tetratricopeptide Repeat X; KDM6A
|
epigenetics histones lysines demthylases chromatins regulators dioxygenases JmjC proteins enzymes recombinants UTY genes chromosomes active |
19.139403519541
|
| 13033 |
Valproic Acid (sodium salt)
|
|
1069-66-5 |
≥95%
|
|
|
2009-10-21
|
32.904732965009
|
valproic-acid-sodium-salt
|
Sodium Valproate; 2-Propylvaleric Acid
|
valeric acids anticonvulsant seizures inhibitors histones deacetylases HDAC glycogen synthase kinases GSK3 inositol-1,4,5-trisphosphate IP3 combination therapy cancers Alzheimer's diseases stem differentiation self-renewal |
32.904732965009
|
| 10944 |
WDR5 (human recombinant)
|
|
- |
≥95%
|
|
|
2011-08-05
|
14.152052839174
|
wdr5-human-recombinant
|
BMP2-induced 3-kb Gene Protein; SWD3, Set1c WD40 repeat protein, homolog; WD-Repeat Protein 5; BIG3
|
epigenetics binding proteins methyltransferase MLL complex subunits |
14.152052839174
|
| 11549 |
WDR9 bromodomain 2 (human recombinant)
New
|
|
- |
≥85%
|
|
|
2012-03-01
|
15.723401238237
|
wdr9-bromodomain-2-human-recombinant
|
WD repeat-containing protein 9; BRD and WD repeat-containing protein 1
|
genes expressions histones chromatin acetylation bromodomains epigenetics BET domain WD repeats Brg1 SMARCA4 |
15.723401238237
|